CCMH
GBT

Cornerstone Capital Management Holdings’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$774K Sell
19,700
-200
-1% -$7.47K 0.01% 949
2017
Q3 		$616K Buy
+19,900
New +$560K ﹤0.01% 1017

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Capital Management Holdings's GBT Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Global Blood Therapeutics, Inc. (GBT) stake by 1% in Q4 2017, selling an estimated $7.47K and leaving 19,700 shares worth $774K. The position accounts for 0.01% of the portfolio, ranked #949.

Cornerstone Capital Management Holdings first reported a position in GBT in Q3 2017 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold GBT as of Q4 2017.

  • Cornerstone Capital Management Holdings held 19,700 shares of Global Blood Therapeutics, Inc. worth $774K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 200 Global Blood Therapeutics, Inc. shares in Q4 2017, an estimated $7.47K.
  • Global Blood Therapeutics, Inc. made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #949 holding.
  • Cornerstone Capital Management Holdings first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.